Credit Suisse Maintains Outperform on Eli Lilly, Raises Price Target to $580
Portfolio Pulse from richadhand@benzinga.com
Credit Suisse analyst Trung Huynh maintains an Outperform rating on Eli Lilly (NYSE:LLY) and raises the price target from $490 to $580.
August 09, 2023 | 12:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Credit Suisse maintains an Outperform rating on Eli Lilly and raises the price target from $490 to $580. This could potentially lead to an increase in the stock's price.
The raised price target by Credit Suisse indicates a positive outlook for Eli Lilly. This could lead to increased investor confidence and potentially an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100